| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 05/05/2005 | US20050095452 Organic element for electroluminescent devices |
| 05/04/2005 | EP1528060A1 Process for preparing 5-hydroxy[b]thiophene-3-carboxylic acid derivatives |
| 05/04/2005 | EP1528055A2 Sulphonamide Derivatives |
| 05/04/2005 | EP1527076A1 Dihydro-dibenzo (b,e) oxepine based selective estrogen receptor modulators, compositions and methods |
| 05/04/2005 | EP1527065A1 Method for the production of (s)-3-methylamino-1-(thien-2-yl)propan-1-ol |
| 05/04/2005 | EP1392672B1 Chloromethylation of thiophene |
| 05/04/2005 | DE19549755B4 Non-solvated crystalline pharmaceutical - comprises 6-hydroxy-2-(4-hydroxyphenyl)-3- (4-(2-piperidino-ethoxy) benzoyl)-benzo(b)-thiophene hydrochloride |
| 05/04/2005 | CN1612869A Novel 1, 2, 4-thiadiazolium derivatives as melanocortin receptor modulators |
| 05/03/2005 | US6888032 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 05/03/2005 | US6887903 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 05/03/2005 | US6887890 For therapy of thrombocytopenia |
| 05/03/2005 | US6887877 Viricide for hepatitis virus |
| 05/03/2005 | US6887876 Benzamidine derivatives |
| 05/03/2005 | US6887871 Use of phenylheteroakylamine derivatives |
| 05/03/2005 | US6887865 N-heterocyclic derivatives as NOS inhibitors |
| 05/03/2005 | US6887863 Such as (2RS,3R)-3-amino-4-cyclohexyl-2-hydroxy-N-phenoxybutanamide; methionine aminopeptidase type 2 inhibitors |
| 05/03/2005 | US6887281 N-heteroarylmethyl-p-phenylenediamine derivatives as well as oxidation dyeing agents containing these compounds |
| 05/03/2005 | CA2236208C Substituted sulphonylamino (thio)carbonyl compounds as herbicides |
| 04/28/2005 | WO2005037843A1 Compositions useful as inhibitors of protein kinases |
| 04/28/2005 | WO2005037810A2 Cyclopropyl methanone derivatives, the preparation and the therapeutic use thereof |
| 04/28/2005 | WO2005037809A1 Substituted aryl cycloalkanol derivatives and methods of their use |
| 04/28/2005 | WO2005037807A1 Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use |
| 04/28/2005 | WO2005037283A1 Fused-aryl and heteroaryl derivatives and methods of their use |
| 04/28/2005 | WO2005037279A1 1- 2’ (1, 4’-biperidin-1’-yl)-1- (phenyl) -ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms |
| 04/28/2005 | WO2005037257A2 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | WO2005037207A2 Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms (vms) |
| 04/28/2005 | WO2005019163A3 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
| 04/28/2005 | WO2004014844A3 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 04/28/2005 | WO2004014842A8 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 04/28/2005 | US20050090669 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 04/28/2005 | US20050090555 Compound for the treatment of metabolic disorders |
| 04/28/2005 | US20050090400 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide |
| 04/28/2005 | CA2549733A1 Fused-aryl and heteroaryl derivatives and methods of their use |
| 04/28/2005 | CA2542723A1 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | CA2542113A1 Compositions useful as inhibitors of protein kinases |
| 04/28/2005 | CA2540207A1 Substituted aryl cycloalkanol derivatives and methods of their use |
| 04/28/2005 | CA2540191A1 1- 2' (1, 4'-biperidin-1'-yl)-1- (phenyl) -ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms |
| 04/28/2005 | CA2539761A1 Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use |
| 04/28/2005 | CA2539755A1 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 04/27/2005 | EP1525199A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 04/27/2005 | EP1525186A1 Inhibitors of hcv ns5b polymerase |
| 04/27/2005 | EP1525183A1 Inhibitors of hcv ns5b polymerase |
| 04/27/2005 | EP1524975A1 Improved transdermal delivery system for the administration of rotigotine |
| 04/27/2005 | EP1366033B1 Chemical compounds |
| 04/27/2005 | EP1144360B1 A method for the synthesis of compounds of formula 1 and derivatives thereof |
| 04/27/2005 | CN1610659A Carboxylic acid derivative |
| 04/27/2005 | CN1610557A 6-fluorobicyclo 3.1.0 hexane derivatives |
| 04/27/2005 | CN1610547A N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor |
| 04/27/2005 | CN1610546A 病毒聚合酶抑制剂 Viral polymerase inhibitor |
| 04/27/2005 | CN1610143A Semiconductor polymer and apparatus thereof |
| 04/27/2005 | CN1198802C Chalcones having antiproliferactive activity |
| 04/27/2005 | CN1198649C Drug composition containing PGD2 antagonists for curing inhibitor |
| 04/27/2005 | CN1198607C Composition for treating or preventing glomerulopathy |
| 04/26/2005 | US6884896 Benzo[b]thiophene derivatives and process for preparing the same |
| 04/26/2005 | US6884821 Alkyloxypropanoic acid derivative containing sulfonamide or amide group are useful as insulin resistance agent |
| 04/26/2005 | US6884815 An amino compound containing imidazole and aromatic, or heteroaromatic rings is useful for treating inflammatory and immune system disorders |
| 04/26/2005 | CA2213124C Benzoyl derivatives |
| 04/21/2005 | WO2005035514A2 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups |
| 04/21/2005 | WO2005035488A2 Thiophene-2-carboxamide derivatives and use thereof as cannabinoid cb-1 receptor antagonists |
| 04/21/2005 | WO2005034880A2 Thiophene and benzothiophene hydroxamic acid derivatives |
| 04/21/2005 | WO2005034878A2 Pyrovalerone analogs and therapeutic uses thereof |
| 04/21/2005 | WO2005026088A3 Compounds based on fluoranthene and use thereof |
| 04/21/2005 | WO2005014525A3 Bi-aryl compound having immunosuppressive activity |
| 04/21/2005 | WO2004062601A3 Antibacterial agents |
| 04/21/2005 | US20050085667 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 04/21/2005 | US20050085531 Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 04/21/2005 | US20050085523 Imidazolyl and pyrazolyl ethyne compounds |
| 04/21/2005 | US20050085516 2-W-diaminocarboxylic acid compounds |
| 04/21/2005 | US20050085512 Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor |
| 04/21/2005 | US20050085511 Cyclic diamines and derivatives as factor Xa inhibitors |
| 04/21/2005 | US20050085504 Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase inhibitors |
| 04/21/2005 | US20050082525 polythiophenes such as poly-(4,8-dihexylbenzo[1,2-b;4,5-b']dithiophene), used as semiconductors or charge transport materials in optical, electro-optical or electronic devices, liquid crystal displays, optical films, transistors, integrated circuits, electroluminescent devices and detectors |
| 04/21/2005 | US20050081310 violet to dark-blue oxidative hari dyes with high intensity, stability, and water stability; color, light, wash, and rubbing fastness, storage stability |
| 04/21/2005 | CA2542096A1 Thiophene and benzothiophene hydroxamic acid derivatives |
| 04/21/2005 | CA2542077A1 Pyrovalerone analogs and therapeutic uses thereof |
| 04/21/2005 | CA2540978A1 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups |
| 04/20/2005 | EP1524271A1 Process for producing 2-alkyl-3-aminothiophene derivative |
| 04/20/2005 | EP1524267A1 Substituted benzylaminoalkylene heterocycles |
| 04/20/2005 | EP1523533A1 Luminescent compositions |
| 04/20/2005 | EP1523479A1 Process for the preparation of 3-hydroxy-(2-thienyl)propanamines |
| 04/20/2005 | EP1425275A4 Novel terthiophene-3-carboxylic acid compound and fabricating method thereof, functionalized conductive terthiophene polymer with the compound as a monomer, process for dna hybridizatioon detection using the polymer, and fabricating method of probe dna |
| 04/20/2005 | EP1349847B1 Oxybenzamides derivatives as factor xa inhibitors |
| 04/20/2005 | EP1299073B1 Agents for colouring keratin fibres, containing derivatives of benzo(b)furane-3-one and/or benzo(b)thiophene-3-one |
| 04/20/2005 | CN1608074A P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions |
| 04/20/2005 | CN1608071A Method of converting functional group through halogen-metal exchange reaction |
| 04/20/2005 | CN1608055A Compounds for the treatment of metabolic disorders |
| 04/19/2005 | US6881755 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 04/19/2005 | US6881741 Such as 3-(4-Chloro-2,5-dimethyl-benzenesulfonylamino)-5-(4-chloro-phenyl)-thiophene-2-carboxylic acid; for treatment of hepatitis |
| 04/19/2005 | US6881735 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/19/2005 | US6881727 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 04/14/2005 | WO2005033102A2 Thiophene-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 04/14/2005 | WO2005033094A2 Methods for the production of 3-methylamino-1-(thiene-2-yl)-propane-1-ol |
| 04/14/2005 | WO2005033069A1 Somatostatin receptor 1 and/or 4 selective agonists and antagonists |
| 04/14/2005 | WO2005033056A2 Triphenylethylene compounds as selective estrogen receptor modulators |
| 04/14/2005 | WO2005032490A2 Cyclic diamines and derivatives as factor xa inhibitors |
| 04/14/2005 | WO2005032471A2 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 04/14/2005 | US20050080121 for example, 4S-[(naphthalene-2-carbonyl)-amino]-5-(2-oxo-pyrrolidin-3S-yl)-pent-2-enoic acid ethyl ester; treatment of viral infections caused by human rhinoviruses, human polioviruses, human coxsackieviruses, human echoviruses, among others |
| 04/14/2005 | US20050080119 Diaminopropionic acid derivatives |
| 04/14/2005 | US20050080115 Novel compounds, their preparation and use |
| 04/14/2005 | US20050080077 Serotonin receptor antagonists such as cis-4,N-dimethyl-N-(3-(4-methylpiperidin-1-yl)cyclopentyl)-benzenesulfonamide for treatment of neurological conditions (depression and sleep disorders) |